---
title: "Halozyme CEO Helen Torley sells USD 4.13 million in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296412342.md"
description: "Halozyme Therapeutics CEO Helen Torley sold approximately USD 4.13 million worth of common shares. Between August 17-19, 2026, she exercised options for 60,000 shares at $18.41 and subsequently sold 59,000 shares at weighted average prices ranging from $98.96 to $107.77. Following these transactions, her direct shareholding stands at 767,780, with remaining option rights reduced to 141,552."
datetime: "2026-08-20T00:01:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296412342.md)
  - [en](https://longbridge.com/en/news/296412342.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296412342.md)
generator: "portal-rs"
---

# Halozyme CEO Helen Torley sells USD 4.13 million in common shares

-   Halozyme: President and CEO Helen Torley exercised options for 60,000 common shares at $18.41 on Aug. 17-19, 2026. \* She sold 59,000 common shares over the same period at weighted average prices of about $98.96 to $107.77. \* Directly held common shares ended at 767,780 following the transactions. \* Options to purchase common stock fell to 141,552, reflecting the three exercises. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Halozyme Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001159036-26-000108), on August 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [HALO.US](https://longbridge.com/en/quote/HALO.US.md)

## Related News & Research

- [Bank of New York Mellon Corp Invests $62.79 Million in Halozyme Therapeutics, Inc. $HALO](https://longbridge.com/en/news/297140434.md)
- [Halozyme CEO Helen Torley disposes of 1,923 common shares worth $146,852.55](https://longbridge.com/en/news/292244402.md)
- [ZIM director Birger Johannes Meyer-Gloeckner disposes of USD 43,633 in common shares](https://longbridge.com/en/news/298312047.md)
- [Klabin board lifts stake by R$ 971,449 via common-share buy at 3.89](https://longbridge.com/en/news/298079756.md)
- [Eynav Azaria Sells 7,816 Shares of Kaltura (NASDAQ:KLTR) Stock](https://longbridge.com/en/news/297933808.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**